Successful treatment of patients with rheumatic disorders and acquired factor VIII inhibitors with cyclophosphamide and prednisolone combination therapy: two case reports.
Acquired haemophilia associated with autoimmune disorders can be fatal and has been reported to be refractory to steroid therapy alone. We report two cases of female patients, aged 24 years and 54 years, with acquired haemophilia caused by factor VIII inhibitors. Underlying diseases were systemic lupus erythematosus in the 24-year-old patient and rheumatoid arthritis in the 54-year-old patient. Both conditions were nearly quiescent when the patients manifested haemorrhagic diathesis. In response to combination therapy with prednisolone and cyclophosphamide, coagulation abnormalities were resolved together with complete elimination of factor VIII inhibitors in both patients. Thus, combination therapy with alkylating agents may be recommended as initial therapy for the management of autoimmune patients with factor VIII inhibitors.
Nishino
Y
Y
Third Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.
Ueki
K
K
Suto
M
M
Uchiumi
H
H
Ota
F
F
Tamura
S
S
Kaneko
Y
Y
Kuroiwa
T
T
Tsukada
Y
Y
Maezawa
A
A
Nojima
Y
Y
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006467:Hemophilia A / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D011239:Prednisolone / Q000627:therapeutic use*; D016896:Treatment Outcome
D003520:Cyclophosphamide; D011239:Prednisolone